If ROCKs are going to be targeted as anti-leukemic agents either as a monotherapy or in combination with existing drugs, a better characterization of the relative contribution of ROCK1 and ROCK2 in disease progression is essential.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660055 | PMC |
| http://dx.doi.org/10.18632/oncotarget.664 | DOI Listing |
Publication Analysis
Top Keywords
targeting rho
4
rho associated
4
associated kinases
4
kinases leukemia
4
leukemia myeloproliferative
4
myeloproliferative neoplasms
4
neoplasms rocks
4
rocks going
4
going targeted
4
targeted anti-leukemic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!